Clinical Trial Data of Novel Metabolic Mechanism in Migraine: CER-0001, a Ketogenic Investigational Agent
- Written by PR Newswire
![]() |
- A poster showcasing data from the RELIEF study of CER-0001 (tricaprilin), being investigated for the preventive treatment of migraine, was presented at the 65th Annual Society Meeting of the American Headache Society
- Data from the pilot study, showed a positive efficacy signal and supports advancement of CER-0001 into pivotal studies
- The poster was...
Read more: Clinical Trial Data of Novel Metabolic Mechanism in Migraine: CER-0001, a Ketogenic...